Skip to Content
Morningstar

Centene Corp CNC

Morningstar Rating
Unlock
Stock XNYS Rating as of
$74.00 −1.68 (2.22%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Centene Earnings: 2024 Outlook Rises, as Individual Plan Strength Helps Offset Medicaid Pullback

Julie Utterback

Narrow-moat Centene exceeded expectations in the first quarter, including strength in its relatively high-margin individual plans, and the company raised its guidance for the full year. However, our bottom-line expectations were already in line with management's new outlook, and after making mild tweaks to our near-term assumptions, our $92 fair value estimate has not changed materially. Centene shares remain moderately undervalued.

Read Full Report

Price vs Fair Value

View History
CNC is trading at a 18% discount.
Price
$75.84
Fair Value
$63.00
Uncertainty
Medium
1-Star Price
$793.30
5-Star Price
$98.70
Economic Moat
Jbdgb
Capital Allocation
Bbzdpqkf

Bulls Say, Bears Say

Bulls

Centene represents a countercyclical investment opportunity in managed care, as it can benefit from economic downturns through increasing enrollment in its Medicaid and individual exchange products.

Bears

Since the pandemic began, Medicaid rolls swelled, but as eligibility redeterminations have resumed, this Centene stronghold may continue to decline in the near future.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CNC is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$75.68
Day Range
$71.25–74.97
52-Week Range
$60.83–81.42
Bid/Ask
$69.50 / $74.74
Market Cap
$39.58 Bil
Volume/Avg
6.4 Mil / 3.1 Mil

Key Statistics

Price/Earnings (Normalized)
11.36
Price/Sales
0.27
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
3.93%

Company Profile

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Sector
Healthcare
Industry
Healthcare Plans
Stock Style Box
Mid Value
Total Number of Employees
67,700
Website
https://www.centene.com

Competitors

Valuation

View More
Metric
CNC
HUM
ELV
Price/Earnings (Normalized)
 11.3613.2515.50
Price/Book Value
 1.572.363.04
Price/Sales
 0.270.360.73
Price/Cash Flow
 8.8311.3413.71
Price/Earnings
CNC
HUM
ELV

Financial Strength

Metric
CNC
HUM
ELV
Quick Ratio
 0.96——
Current Ratio
 1.11——
Interest Coverage
 5.967.868.49
Quick Ratio
CNC
HUM
ELV

Profitability

Metric
CNC
HUM
ELV
Return on Assets (Normalized)
 4.42%5.46%7.36%
Return on Equity (Normalized)
 14.34%17.15%20.87%
Return on Invested Capital (Normalized)
 9.26%11.21%13.85%
Return on Assets
CNC
HUM
ELV
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Healthcare Plans Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
UNH
UnitedHealth Group IncGjcbdydsndVcsdm$455.8 Bil
ELV
Elevance Health IncGmfpybbZjdbkw$124.9 Bil
CI
The Cigna GroupRdwyqxpYdwbgql$100.6 Bil
CVS
CVS Health CorpTtsdvrbvSnjylbb$84.7 Bil
HUM
Humana IncZnwfbnwjmMgmgkv$37.5 Bil
MOH
Molina Healthcare Inc—Vdwzdjm$20.0 Bil
OSCR
Oscar Health Inc Class A—Jst$4.0 Bil
ALHC
Alignment Healthcare Inc—Hnpp$984.6 Mil
CLOV
Clover Health Investments Corp Ordinary Shares - Class A—Yppk$336.8 Mil

Sponsor Center